A team of scientists from A*STAR’s Genome Institute of Singapore (GIS) and Bioinformatics Institute (BII) has deve...
Guangzhou-Israel Biotechnology Fund (GIBF) has invested $10 million in Nectin Therapeutics. Israel-b...
Rabies is a neglected zoonotic disease caused by RNA virus from Rhabdoviridae family, potentially fatal if not treated. ...
In a groundbreaking study published in Cell Research, researchers from the Yong Loo Lin School of Medicine at the Nation...
Research led by the University of Sydney and Sydney Local Health District has developed a new type of oral insulin bas...
Ora, Inc., a US-based ophthalmology contract research organisation (CRO), has announced a strategic, exclusive partnersh...
How is Agilent advancing cell and gene therapy modalities to enable next-gen therapeutics and applications? What are A...
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore fa...
The Paula Fox Melanoma and Cancer Centre, a partnership between Monash University, The Alfred and Minderoo Foundation, i...
In Hong Kong, one in three adults over the age of 65 have diabetes. To improve the management of this group of older adu...
South Korea-based biotech startup OSR Holdings has signed a Memorandum of Understanding (MoU) with SillaJen, a Kosdaq-li...
SCG Cell Therapy (SCG) and the Agency for Science, Technology and Research (A*STAR) have announced the launch joint labo...
The National University Hospital (NUH) in Singapore is embarking on a major initiative to establish the N...
Seaport Therapeutics, a clinical-stage biopharmaceutical company based around a unique drug delivery platform originally...
Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells,...
Scientists have discovered a target for the development of a drug to combat a bacterium that can cause chronic lung infe...
Monash Partners Comprehensive Cancer Consortium (MPCCC) has announced the recipients of the Precision Treatment Accelera...
Ascend Advanced Therapies (Ascend), a total solutions gene therapy development partner, has acquired the CMC ...
